NEW YORK (GenomeWeb) – GMSbiotech and Pure Protein announced today that they have received a $2.6 million grant from the National Institutes of Health to develop a donor-specific antibody (DSA) diagnostic for use in organ transplant patients.

The companies will combine GMSbiotech's proprietary microarray platform with soluble human leukocyte antigen proteins produced by Pure Protein. The resulting assay will be designed to analyze patients' DSA levels for the detection of antibody-mediated rejection of transplants.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.